Page last updated: 2024-11-04

sb 202190 and Cell Transformation, Neoplastic

sb 202190 has been researched along with Cell Transformation, Neoplastic in 3 studies

4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole: structure given in first source; inhibits p38 MAP kinase

Cell Transformation, Neoplastic: Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Menon, MB1
Kotlyarov, A1
Gaestel, M1
He, Z1
Cho, YY1
Liu, G1
Ma, WY1
Bode, AM1
Dong, Z1
Woods Ignatoski, KM1
Livant, DL1
Markwart, S1
Grewal, NK1
Ethier, SP1

Other Studies

3 other studies available for sb 202190 and Cell Transformation, Neoplastic

ArticleYear
SB202190-induced cell type-specific vacuole formation and defective autophagy do not depend on p38 MAP kinase inhibition.
    PloS one, 2011, Volume: 6, Issue:8

    Topics: Animals; Autophagy; Cell Line, Tumor; Cell Transformation, Neoplastic; Cricetinae; Down-Regulation;

2011
p38 Mitogen-activated protein kinase regulation of JB6 Cl41 cell transformation promoted by epidermal growth factor.
    The Journal of biological chemistry, 2003, Jul-18, Volume: 278, Issue:29

    Topics: Activating Transcription Factor 2; Animals; Cell Line; Cell Transformation, Neoplastic; Cyclic AMP R

2003
The role of phosphatidylinositol 3'-kinase and its downstream signals in erbB-2-mediated transformation.
    Molecular cancer research : MCR, 2003, Volume: 1, Issue:7

    Topics: Cell Line; Cell Transformation, Neoplastic; Chemotaxis; Enzyme Inhibitors; Humans; Imidazoles; Phago

2003